This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Redente, E. F. Articles by Malkinson, A. M. Search for Related Content PubMed PubMed Citation Articles by Redente, E. F. Articles by Malkinson, A. M.

(American Journal of Pathology. 2007;170:693-708.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060566

Tumor Signaling to the Bone Marrow Changes the Phenotype of Monocytes and Pulmonary Macrophages during Urethane-Induced Primary Lung Tumorigenesis in A/J Mice

Elizabeth F. Redente^*, David J. Orlicky, Ronald J. Bouchard and Alvin M. Malkinson^*

From the Departments of Pharmaceutical Sciences^* and Pathology, University of Colorado at Denver and Health Sciences Center, Denver; and the Department of Veterans Affairs, Veterans Administration Medical Center, Denver, Colorado

Little is known about how the composition of stromal cells within the lung cancer microenvironment varies during tumor progression. We examined by immunohistochemistry each of six different stromal cell populations during the development of chemically induced primary lung cancer in mice. Blood vessels were seen even in microscopic lesions, and their numbers increased with tumor size. Neutrophils infiltrated the alveoli of tumor-bearing lungs and within the periphery of macroscopic adenomas and adenocarcinomas. The numbers of peritumoral lymphocytes and macrophages increased during oncogeny, but quantitative changes in mast cells and fibroblasts were not evident. Because macrophage depletion reduces tumor growth and these cells are thus important to tumorigenesis, we also investigated their phenotype. Pulmonary macrophages expressed arginase I (subtype M2) but not inducible nitric-oxide synthase in lungs with premalignant lesions, whereas macrophages in carcinoma-bearing lungs expressed inducible nitric-oxide synthase (subtype M1) but not arginase I. Local pulmonary stimuli did not seem responsible for this shift in macrophage activation state because monocytes still residing within the bone marrow adopted these expression patterns before entering the circulation, presumably in response to tumor-derived signals. These biochemical markers of macrophage activation states would have diagnostic and/or therapeutic value if analogous systemic shifts occur in humans.

This article has been cited by other articles:

				G. Chan, E. R. Bivins-Smith, M. S. Smith, P. M. Smith, and A. D. Yurochko Transcriptome Analysis Reveals Human Cytomegalovirus Reprograms Monocyte Differentiation toward an M1 Macrophage J. Immunol., July 1, 2008; 181(1): 698 - 711. [Abstract] [Full Text] [PDF]

				A. D. Joshi, T. Raymond, A. L. Coelho, S. L. Kunkel, and C. M. Hogaboam A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone marrow-derived macrophages to Toll-like receptor agonists J. Leukoc. Biol., February 1, 2008; 83(2): 314 - 324. [Abstract] [Full Text] [PDF]

				R. S. Stearman, L. Dwyer-Nield, M. C. Grady, A. M. Malkinson, and M. W. Geraci A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment Cancer Res., January 1, 2008; 68(1): 34 - 43. [Abstract] [Full Text] [PDF]

				L. M. Montuenga and R. Pio Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10 Eur. Respir. J., October 1, 2007; 30(4): 608 - 610. [Full Text] [PDF]